Eric Liu


Mr. Liu has served as Partner and Global Co-Head of Healthcare at EQT, an alternative asset management firm in Sweden, with over €70 billion in assets under management. Mr. Liu led the firm’s investments and serves on the Board of Directors of the Company, Parexel, a Clinical research organization company, and Waystar, Inc., a healthcare revenue cycle management company, and was previously responsible for Aldevron and Press Ganey. Prior to joining EQT, Mr. Liu spent ten years at Warburg Pincus where he was responsible for private equity investments in the healthcare sector, including Bausch & Lomb, Tornier, ev3, and DexCom. Earlier in his career, he worked in private equity at The Blackstone Group and in early-stage venture capital at Draper Fisher Jurvetson.

Mr. Liu has a B.A. in Applied Mathematics, phi beta kappa, from Harvard University and an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar.

Independent Director